Overview

To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-23
Target enrollment:
Participant gender:
Summary
This study was conducted to evaluate recombinant human follicle stimulating hormone-CTP fusion protein injection or placebo combined with chorionic gonadotropin for injection
Phase:
PHASE3
Details
Lead Sponsor:
Changchun GeneScience Pharmaceutical Co., Ltd.